Literature DB >> 2912362

Chronic lymphocytic leukemia: recommendations for diagnosis, staging, and response criteria. International Workshop on Chronic Lymphocytic Leukemia.

.   

Abstract

Entities:  

Mesh：

Year:  1989        PMID： 2912362     DOI： 10.7326/0003-4819-110-3-236

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  17 in total

Review 1.  New directions in the diagnosis and treatment of chronic lymphocytic leukaemia.

Authors:  Folke Schriever; Dieter Huhn
Journal:  Drugs       Date:  2003       Impact factor: 9.546

2.  Risk categories and refractory CLL in the era of chemoimmunotherapy.

Authors:  Thorsten Zenz; John G Gribben; Michael Hallek; Hartmut Döhner; Michael J Keating; Stephan Stilgenbauer
Journal:  Blood       Date:  2012-03-06       Impact factor: 22.113

3.  Prognostic significance of the heterogenous expression of IgG Fc receptors in B-cell chronic lymphocytic leukemia.

Authors:  V Schranz; F Gráf
Journal:  Ann Hematol       Date:  1992-03       Impact factor: 3.673

4.  Treatment of early stage-B chronic lymphocytic leukemia with alpha-2b interferon after chlorambucil reduction of the tumoral mass.

Authors:  E Montserrat; N Villamor; A Urbano-Ispizua; J M Ribera; M Lozano; J L Vives-Corrons; C Rozman
Journal:  Ann Hematol       Date:  1991-07       Impact factor: 3.673

5.  Development of chronic lymphocytic leukaemia after posttraumatic splenectomy.

Authors:  J Demeter; K Pálóczi; P Vargha; D Lehoczky
Journal:  Blut       Date:  1990-06

6.  Establishment of a novel B cell clonality analysis using single-strand conformation polymorphism of immunoglobulin light chain messenger signals.

Authors:  S Shiokawa; J Nishimura; K Ohshima; N Uike; K Yamamoto
Journal:  Am J Pathol       Date:  1998-11       Impact factor: 4.307

Review 7.  [Chronic lymphatic leukemia and hairy cell leukemia. Diagnosis and therapy].

Authors:  G Brittinger; K P Hellriegel; W Hiddemann
Journal:  Med Klin (Munich)       Date:  1997-06-15

8.  Campath-1H in B-chronic lymphocytic leukemia: report on a patient treated thrice in a 3 year period.

Authors:  G A Pangalis; M N Dimopoulou; M K Angelopoulou; C H Tsekouras; M P Siakantaris
Journal:  Med Oncol       Date:  2000-02       Impact factor: 3.064

Review 9.  Fludarabine. A review of its pharmacological properties and therapeutic potential in malignancy.

Authors:  S R Ross; D McTavish; D Faulds
Journal:  Drugs       Date:  1993-05       Impact factor: 9.546

10.  Phase I/II evaluation of pentostatin (2'-deoxycoformycin) in a five day schedule for the treatment of relapsed/refractory B-cell chronic lymphocytic leukaemia.

Authors:  S A Johnson; D Catovsky; J A Child; A C Newland; D W Milligan; R Janmohamed
Journal:  Invest New Drugs       Date:  1998       Impact factor: 3.850
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.